Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mj21
    Junior Member
    • Apr 2014
    • 1

    #1

    FPKM despite no length ~ count correlation?

    Hi all,

    I am working with Illumina HiSeq paired-end reads mapped with Bowtie2 to a bacterial reference genome in 3 biological replicates. By now, I pursued two strategies to quantify the mapped reads per gene.
    (1) Used HTSeq (union- mode) to get read counts followed by TMM normalisation
    (2) Used Cufflinks to calculate FPKMs (with and w.o. length correction)

    Since I have only biological replicates but no different treatments/conditions my aim is to make more general statements about gene expression (like mean values) under this one condition and not necessarily assessing differential expression between the biol. replicates.
    I'm new in the field of RNA-seq but hardly realised that there are lots of tools but few standards. However, consensus seems to be that comparing gene expression within one genome requires normalisation by gene length and comparisons between same genes but different samples normalization by library size.
    But as I tested correlation between HTSeq counts and gene length I found no correlation at all.

    (A) is it ok to normalise for length despite of a missing count vs. gene_length correlation
    (B) What would you recommend for a quantification/ normalisation strategy in my specific case?

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:05 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...